封面
市場調查報告書
商品編碼
1994800

全球媒介傳播疾病監測人工智慧(AI)市場報告(2026年)

Vector-Borne Disease Surveillance Artificial Intelligence (AI) Global Market Report 2026

出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來,用於病原體傳播疾病監測的人工智慧(AI)市場發展迅速。預計該市場將從2025年的16億美元成長到2026年的19.2億美元,複合年成長率(CAGR)為19.9%。過去幾年成長要素包括病原體傳播疾病發病率的上升、公共衛生監測項目的擴展、地理空間健康數據的成長、全球健康監測計劃的實施以及數位化疾病報告的普及。

預計未來幾年,用於媒介傳播疾病監測的人工智慧(AI)市場將大幅成長,到2030年將達到40.1億美元,複合年成長率(CAGR)為20.2%。預測期內的成長要素包括對人工智慧驅動的疫情預測的需求、氣候變遷導致的媒介傳播擴散、智慧感測器監測網路、跨境健康數據平台以及預測性公共衛生規劃。預測期內的關鍵趨勢包括人工智慧驅動的疫情預測模型、與氣候變遷相關的媒介風險地圖繪製、自動化物種識別系統、即時流行病學儀錶板以及整合的多源監測平台。

預計未來幾年,媒介傳播疾病發生率的上升將推動人工智慧(AI)在媒介傳播疾病監測領域的市場擴張。媒介傳播疾病是由蚊子、蜱蟲和跳蚤等媒介傳播的病原體引起的疾病,正日益成為全球公共衛生領域的嚴峻挑戰。氣候變遷、都市化、人口遷移以及媒介棲息地的擴張是導致這些疾病增加的主要原因,使得疾病的地理覆蓋範圍更廣,發病率更高。人工智慧驅動的媒介傳播疾病監測將有助於應對這些挑戰,其實現即時數據整合、早期疫情檢測、預測分析以及更有效地分配公共衛生資源。例如,根據泛美衛生組織(PAHO)的數據(由英國衛生與安全局於2024年6月發布),2024年1月至6月期間,美洲共記錄了9,386,082例登革熱病例(4,630,669例確診病例和4,529例死亡病例),比2023年同期成長了123.29%。因此,媒介傳播疾病發生率的上升正在推動媒介傳播疾病監測人工智慧市場的成長。

在媒介傳播疾病監測人工智慧市場中,主要企業正致力於即時媒介預測技術的進步,例如人工智慧驅動的智慧監測系統,以期透過提高疫情預測的準確性、增強精準干預能力和提升公共衛生決策水平來獲得競爭優勢。這些系統將人工智慧與物聯網感測器和分析功能結合,用於監測蚊蟲族群、檢測蚊蟲種類和環境狀況,並觸發針對性干預警報,從而實現比傳統方法更準確、更及時的公共衛生反應。例如,2025年7月,印度公共部門城市發展機構-安得拉邦市政管理和城市發展局(Andhra Pradesh Municipal Administration and Urban Development Authority)部署了智慧蚊蟲監測系統(SMoSS)。 SMoSS提供了一個人工智慧驅動的即時監測平台,用於追蹤高風險都市區的蚊蟲族群。該系統整合了智慧感測器、誘捕器、無人機和物聯網基礎設施,用於收集連續的現場數據並產生熱力圖,以識別蚊蟲滋生地和疫情爆發熱點。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球媒介傳播疾病監測人工智慧(AI)市場:吸引力評分及分析
  • 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 清單:主要原料、資源和供應商
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章:全球市場趨勢與策略

  • 關鍵科技與未來趨勢
    • 人工智慧(AI)和自主人工智慧
    • 生物技術、基因組學和精準醫療
    • 數位化、雲端運算、巨量資料、網路安全
    • 物聯網、智慧基礎設施、互聯生態系統
    • 永續性、氣候技術、循環經濟
  • 主要趨勢
    • 人工智慧驅動的感染疾病爆發預測模型
    • 氣候相關病媒風險圖
    • 自動物種辨識系統
    • 即時流行病學儀表板
    • 整合多源監測平台

第5章 終端用戶產業市場分析

  • 政府公共衛生機構
  • 醫療保健提供者
  • 研究機構
  • 流行病學中心
  • 非營利性衛生組織

第6章 市場:宏觀經濟情景,包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響,以及 COVID-19 疫情對市場的影響。

第7章:全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球媒介傳播疾病監測人工智慧(AI)市場:PESTEL 分析(政治、社會、技術、環境、法律因素、促進因素和限制因素)
  • 全球媒介傳播疾病監測人工智慧(AI)市場規模、對比及成長率分析
  • 全球媒介傳播疾病監測人工智慧(AI)市場表現:規模與成長,2020-2025年
  • 全球媒介傳播疾病監測人工智慧(AI)市場預測:規模與成長,2025-2030年,2035年預測

第8章:全球市場總規模(TAM)

第9章 市場細分

  • 按組件
  • 軟體、硬體和服務
  • 部署模式
  • 基於雲端,本地部署
  • 透過使用
  • 瘧疾監測、登革熱監測、茲卡病毒監測、萊姆病追蹤及其他用途
  • 最終用戶
  • 政府機構、醫療保健提供者、研究機構和其他最終用戶
  • 按類型細分:軟體
  • 預測分析軟體、資料管理軟體、視覺化軟體、報表和儀表板軟體、地理空間地圖繪製軟體
  • 按類型細分:硬體
  • 感測器和偵測設備、穿戴式監控設備、監視錄影機、資料儲存設備、網路設備
  • 按類型細分:服務
  • 諮詢服務、實施服務、維護和支援服務、培訓和教育服務、整合服務

第10章 區域與國別分析

  • 全球媒介傳播疾病監測人工智慧(AI)市場:按地區分類,實際值和預測值,2020-2025年、2025-2030年預測值、2035年預測值
  • 全球媒介傳播疾病監測人工智慧(AI)市場:按國家分類,實際值和預測值,2020-2025年、2025-2030年預測值、2035年預測值

第11章 亞太市場

第12章:中國市場

第13章:印度市場

第14章:日本市場

第15章:澳洲市場

第16章:印尼市場

第17章:韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章:德國市場

第23章:法國市場

第24章:義大利市場

第25章:西班牙市場

第26章:東歐市場

第27章:俄羅斯市場

第28章 北美市場

第29章:美國市場

第30章:加拿大市場

第31章:南美市場

第32章:巴西市場

第33章 中東市場

第34章:非洲市場

第35章 市場監理與投資環境

第36章:競爭格局與公司概況

  • 媒介傳播疾病監測人工智慧(AI)市場:競爭格局與市場佔有率,2024年
  • 媒介傳播疾病監測人工智慧(AI)市場:公司估值矩陣
  • 媒介傳播疾病監測人工智慧(AI)市場:公司概況
    • Amazon Web Services Inc.
    • Microsoft Corporation
    • International Business Machines Corporation
    • Siemens Healthineers AG
    • Plexus Health Surveillance

第37章 其他大型企業和創新企業

  • SAS Institute Inc., Palantir Technologies Inc., Informatica LLC, Vector Surveillance System, Environmental Systems Research Institute Inc., Cloudera Inc., HealthMap, GIDEON Informatics, Metabiota Inc., EcoHealth Alliance Inc., BlueDot Inc., BioSense Technologies, Artificial Intelligence in Medical Epidemiology, Vector Technology & Management Consulting Group, Aira Matrix

第38章:全球市場競爭基準分析與儀錶板

第39章:預計進入市場的Start-Ups

第40章 重大併購

第41章 具有高市場潛力的國家、細分市場與策略

  • 2030年媒介傳播疾病監測人工智慧(AI)市場:提供新機會的國家
  • 2030年媒介傳播疾病監測人工智慧(AI)市場:提供新機會的細分領域
  • 2030年媒介傳播疾病監測人工智慧(AI)市場:成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第42章附錄

簡介目錄
Product Code: IT4MVBDS01_G26Q1

Vector borne disease surveillance artificial intelligence (AI) involves the application of AI technologies to monitor, predict, and control diseases transmitted by vectors such as mosquitoes, ticks, and other insects. It analyzes environmental, climate, and health data to identify trends and forecast outbreaks with greater precision. This system supports faster responses and more effective public health interventions through real-time analysis of complex datasets.

The primary components of vector-borne disease surveillance artificial intelligence (AI) include software, hardware, and services. Software consists of AI-driven platforms that gather, process, and forecast the transmission patterns of vector-borne diseases using real-time data inputs. These platforms can be implemented through cloud-based environments or on-premises deployments. They are applied in malaria surveillance, dengue monitoring, Zika virus tracking, Lyme disease surveillance, and other applications, and are used by end users such as government agencies, healthcare providers, research institutes, and other end users.

Tariffs are affecting the vector borne disease surveillance AI market mainly through increased costs of imported sensors, field detection devices, and surveillance hardware. Higher duties on monitoring equipment and networking devices are raising deployment costs for public health agencies and research programs. Regions dependent on imported sensing and diagnostic hardware are seeing slower rollout of integrated surveillance systems. Hardware intensive field monitoring segments are more exposed than pure software analytics platforms. Cloud based AI tools are less directly impacted by tariff changes. At the same time, tariffs are encouraging local manufacturing of sensing and monitoring equipment. This supports regional health technology suppliers and system integrators.

The vector-borne disease surveillance artificial intelligence (AI) market research report is one of a series of new reports from The Business Research Company that provides vector-borne disease surveillance artificial intelligence (AI) market statistics, including vector-borne disease surveillance artificial intelligence (AI) industry global market size, regional shares, competitors with a vector-borne disease surveillance artificial intelligence (AI) market share, detailed vector-borne disease surveillance artificial intelligence (AI) market segments, market trends and opportunities, and any further data you may need to thrive in the vector-borne disease surveillance artificial intelligence (AI) industry. This vector-borne disease surveillance artificial intelligence (AI) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The vector-borne disease surveillance artificial intelligence (AI) market size has grown rapidly in recent years. It will grow from $1.6 billion in 2025 to $1.92 billion in 2026 at a compound annual growth rate (CAGR) of 19.9%. The growth in the historic period can be attributed to increase in vector borne disease outbreaks, expansion of public health surveillance programs, growth in geospatial health data, global health monitoring initiatives, adoption of digital disease reporting.

The vector-borne disease surveillance artificial intelligence (AI) market size is expected to see exponential growth in the next few years. It will grow to $4.01 billion in 2030 at a compound annual growth rate (CAGR) of 20.2%. The growth in the forecast period can be attributed to AI based epidemic forecasting demand, climate change driven vector spread, smart sensor surveillance networks, cross border health data platforms, predictive public health planning. Major trends in the forecast period include AI driven outbreak prediction models, climate linked vector risk mapping, automated species identification systems, real time epidemiological dashboards, integrated multi source surveillance platforms.

The rising incidence of vector-borne diseases is expected to support the expansion of the vector-borne disease surveillance artificial intelligence (AI) market in the coming years. Vector-borne diseases are illnesses caused by pathogens transmitted through vectors such as mosquitoes, ticks, and fleas, and they represent a growing global public health challenge. The increasing occurrence of these diseases is driven by climate change, urbanization, population movement, and expanding vector habitats, which have resulted in wider geographic spread and more frequent outbreaks. AI-powered vector-borne disease surveillance helps address these challenges by enabling real-time data integration, early outbreak identification, predictive analytics, and improved allocation of public health resources. For example, according to the Pan American Health Organization (PAHO), as reported by the UK Health Security Agency in June 2024, the Region of the Americas recorded 9,386,082 dengue cases, including 4,630,669 confirmed cases and 4,529 deaths between January and June 2024, representing a 103.29% increase compared to the same period in 2023. Therefore, the rising incidence of vector-borne diseases is advancing the growth of the vector-borne disease surveillance AI market.

Leading companies operating in the vector-borne disease surveillance AI market are focusing on technological advancements in real-time vector prediction, such as AI-powered smart surveillance systems, to gain competitive advantage through improved outbreak forecasting, targeted intervention capabilities, and enhanced public health decision-making. These systems integrate artificial intelligence with Internet-of-Things sensors and analytics to monitor mosquito populations, detect species and environmental conditions, and trigger alerts for targeted interventions, enabling more precise and timely public health responses compared to traditional methods. For instance, in July 2025, the Andhra Pradesh Municipal Administration and Urban Development Department, a public sector urban development entity in India, introduced the Smart Mosquito Surveillance System (SMoSS). The Smart Mosquito Surveillance System (SMoSS) provides an AI-driven, real-time monitoring platform to track mosquito populations in high-risk urban areas. It integrates smart sensors, traps, drones, and IoT infrastructure to collect continuous field data and generate heat maps identifying mosquito breeding and infestation hotspots.

In June 2025, bioMerieux, a France-based provider of in vitro diagnostic technologies, acquired the assets of Day Zero Diagnostics for an undisclosed amount. This acquisition aims to enhance bioMerieux's next-generation sequencing and machine learning capabilities, enabling faster identification of infectious pathogens and antibiotic resistance profiles for real-time disease surveillance. Day Zero Diagnostics is a US-based company specializing in machine learning-powered genome sequencing solutions for rapid pathogen detection.

Major companies operating in the vector-borne disease surveillance artificial intelligence (AI) market are Amazon Web Services Inc., Microsoft Corporation, International Business Machines Corporation, Siemens Healthineers AG, Plexus Health Surveillance, SAS Institute Inc., Palantir Technologies Inc., Informatica LLC, Vector Surveillance System, Environmental Systems Research Institute Inc., Cloudera Inc., HealthMap, GIDEON Informatics, Metabiota Inc., EcoHealth Alliance Inc., BlueDot Inc., BioSense Technologies, Artificial Intelligence in Medical Epidemiology, Vector Technology & Management Consulting Group, Aira Matrix

North America was the largest region in the vector-borne disease surveillance Artificial Intelligence (AI) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vector-borne disease surveillance artificial intelligence (AI) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the vector-borne disease surveillance artificial intelligence (AI) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The vector borne disease surveillance artificial intelligence (AI) market consists of revenues earned by entities by providing services such as real-time vector monitoring, outbreak prediction, data analysis and modeling, risk assessment, reporting and visualization, early warning alerts, decision support, public health intervention planning, predictive analytics, and surveillance system integration. The vector borne disease surveillance artificial intelligence (AI) market also includes sales of AI-powered species identification tools, smart surveillance & monitoring platforms, risk forecasting systems, community reporting apps, and pathogen detection platforms. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses vector-borne disease surveillance artificial intelligence (AI) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for vector-borne disease surveillance artificial intelligence (AI) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The vector-borne disease surveillance artificial intelligence (AI) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Component: Software; Hardware; Services
  • 2) By Deployment Mode: Cloud-Based; On-Premises
  • 3) By Application: Malaria Surveillance; Dengue Surveillance; Zika Virus Monitoring; Lyme Disease Tracking; Other Applications
  • 4) By End-User: Government Agencies; Healthcare Providers; Research Institutes; Other End Users
  • Subsegments:
  • 1) By Software: Predictive Analytics Software; Data Management Software; Visualization Software; Reporting and Dashboard Software; Geospatial Mapping Software
  • 2) By Hardware: Sensors and Detection Devices; Wearable Monitoring Devices; Surveillance Cameras; Data Storage Devices; Networking Devices
  • 3) By Services: Consulting Services; Implementation Services; Maintenance and Support Services; Training and Education Services; Integration Services
  • Companies Mentioned: Amazon Web Services Inc.; Microsoft Corporation; International Business Machines Corporation; Siemens Healthineers AG; Plexus Health Surveillance; SAS Institute Inc.; Palantir Technologies Inc.; Informatica LLC; Vector Surveillance System; Environmental Systems Research Institute Inc.; Cloudera Inc.; HealthMap; GIDEON Informatics; Metabiota Inc.; EcoHealth Alliance Inc.; BlueDot Inc.; BioSense Technologies; Artificial Intelligence in Medical Epidemiology; Vector Technology & Management Consulting Group; Aira Matrix
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Sustainability, Climate Tech & Circular Economy
  • 4.2. Major Trends
    • 4.2.1 AI Driven Outbreak Prediction Models
    • 4.2.2 Climate Linked Vector Risk Mapping
    • 4.2.3 Automated Species Identification Systems
    • 4.2.4 Real Time Epidemiological Dashboards
    • 4.2.5 Integrated Multi Source Surveillance Platforms

5. Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Analysis Of End Use Industries

  • 5.1 Government Public Health Agencies
  • 5.2 Healthcare Providers
  • 5.3 Research Institutes
  • 5.4 Epidemiology Centers
  • 5.5 Nonprofit Health Organizations

6. Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Vector-Borne Disease Surveillance Artificial Intelligence (AI) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Vector-Borne Disease Surveillance Artificial Intelligence (AI) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Vector-Borne Disease Surveillance Artificial Intelligence (AI) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Vector-Borne Disease Surveillance Artificial Intelligence (AI) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Vector-Borne Disease Surveillance Artificial Intelligence (AI) Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Segmentation

  • 9.1. Global Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Software, Hardware, Services
  • 9.2. Global Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cloud-Based, On-Premises
  • 9.3. Global Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Malaria Surveillance, Dengue Surveillance, Zika Virus Monitoring, Lyme Disease Tracking, Other Applications
  • 9.4. Global Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Government Agencies, Healthcare Providers, Research Institutes, Other End Users
  • 9.5. Global Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Predictive Analytics Software, Data Management Software, Visualization Software, Reporting and Dashboard Software, Geospatial Mapping Software
  • 9.6. Global Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Sensors and Detection Devices, Wearable Monitoring Devices, Surveillance Cameras, Data Storage Devices, Networking Devices
  • 9.7. Global Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Consulting Services, Implementation Services, Maintenance and Support Services, Training and Education Services, Integration Services

10. Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Regional And Country Analysis

  • 10.1. Global Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 11.1. Asia-Pacific Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 12.1. China Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 13.1. India Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 14.1. Japan Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 15.1. Australia Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 16.1. Indonesia Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 17.1. South Korea Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 18.1. Taiwan Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 19.1. South East Asia Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 20.1. Western Europe Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 21.1. UK Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 22.1. Germany Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 23.1. France Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 24.1. Italy Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 25.1. Spain Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 26.1. Eastern Europe Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 27.1. Russia Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 28.1. North America Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 29.1. USA Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 30.1. Canada Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 31.1. South America Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 32.1. Brazil Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 33.1. Middle East Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 34.1. Africa Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Regulatory and Investment Landscape

36. Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Competitive Landscape And Company Profiles

  • 36.1. Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Company Profiles
    • 36.3.1. Amazon Web Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. International Business Machines Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Plexus Health Surveillance Overview, Products and Services, Strategy and Financial Analysis

37. Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Other Major And Innovative Companies

  • SAS Institute Inc., Palantir Technologies Inc., Informatica LLC, Vector Surveillance System, Environmental Systems Research Institute Inc., Cloudera Inc., HealthMap, GIDEON Informatics, Metabiota Inc., EcoHealth Alliance Inc., BlueDot Inc., BioSense Technologies, Artificial Intelligence in Medical Epidemiology, Vector Technology & Management Consulting Group, Aira Matrix

38. Global Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

41. Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market High Potential Countries, Segments and Strategies

  • 41.1 Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market In 2030 - Countries Offering Most New Opportunities
  • 41.2 Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market In 2030 - Segments Offering Most New Opportunities
  • 41.3 Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market In 2030 - Growth Strategies
    • 41.3.1 Market Trend Based Strategies
    • 41.3.2 Competitor Strategies

42. Appendix

  • 42.1. Abbreviations
  • 42.2. Currencies
  • 42.3. Historic And Forecast Inflation Rates
  • 42.4. Research Inquiries
  • 42.5. The Business Research Company
  • 42.6. Copyright And Disclaimer